Generalizing Conditional Average Treatment Effects From Nested Randomized Trials to Trial‐Eligible Individuals
Statistics in Medicine · 2026
DOI: 10.1002/sim.70767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, 2026. Verfasst von Lan Wen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Randomized controlled trials often enroll participants whose characteristics differ from those of a target population. When the distribution of effect modifiers differs between trial participants and the target population, treatment effects estimated within the trial may not be directly applicable to all trial‐eligible individuals. Although substantial progress has been made in generalizing average treatment effects from randomized trials to target populations, clinical and policy decisions are often informed by conditional average treatment effects (CATEs) that characterize heterogeneity across selected effect modifiers in the target population. In this work, we provide a unified approach for estimating CATEs in a target population of trial‐eligible individuals under a nested trial design. Our approach first estimates nuisance functions using data‐adaptive methods and constructs pseudo‐outcomes from conditional influence functions. These pseudo‐outcomes are subsequently regressed on pre‐specified effect modifiers using local linear (kernel) regression to obtain a smoothed estimate of the CATE function. We establish asymptotic properties under sample splitting and cross‐fitting, and provide conditions under which first‐stage nuisance estimation has negligible impact on the final estimator. We assess the finite‐sample performance of the proposed estimator via simulation studies, and illustrate its practical use through an application to the Coronary Artery Surgery Study (CASS).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada.
- Department of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.
- Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, Rhode Island, USA.
ORCID-Profile: Lan Wen, Issa J Dahabreh, Yu-Han Chiu
Förderung
- NIGMS NIH HHS
- NHLBI NIH HHS
- Natural Sciences and Engineering Research Council of Canada
- NLM NIH HHS
- Patient-Centered Outcomes Research Institute
- National Institute of General Medical Sciences
- U.S. National Library of Medicine
- National Heart, Lung, and Blood Institute
Zitieren
APA
Wen, L., Dahabreh, I. J., & Chiu, Y. H. (2026). Generalizing Conditional Average Treatment Effects From Nested Randomized Trials to Trial‐Eligible Individuals. Statistics in Medicine. https://doi.org/10.1002/sim.70767
Vancouver
Wen L, Dahabreh IJ, Chiu YH. Generalizing Conditional Average Treatment Effects From Nested Randomized Trials to Trial‐Eligible Individuals. Statistics in Medicine. 2026. doi:10.1002/sim.70767
BibTeX
@article{Wen2026,
author = {Wen, Lan and Dahabreh, Issa J and Chiu, Yu-Han},
title = {Generalizing Conditional Average Treatment Effects From Nested Randomized Trials to Trial‐Eligible Individuals},
journal = {Statistics in Medicine},
year = {2026},
doi = {10.1002/sim.70767}
}
EUVIMED